Evidence map›Paper›PMID 41304830›Full record

ArticlePharmaceutics2025

Bis-Oxadiazole Assemblies as NO-Releasing Anticancer Agents.

Egor M Matnurov, Irina A Stebletsova, Alexander A Larin, Jemma Arakelyan, Ivan V Ananyev, Artem L Gushchin, Leonid L Fershtat, Maria V Babak

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Egor M MatnurovDrug Discovery Lab, Department of Chemistry, City University of Hong Kong, 83 Tat Chee Avenue, Hong Kong SAR, China.ORCID 0009-0007-2297-9781
Irina A StebletsovaN.D. Zelinsky Institute of Organic Chemistry, Russian Academy of Sciences, 47 Leninsky Prosp., 119991 Moscow, Russia.ORCID 0000-0001-6117-829X
Alexander A LarinN.D. Zelinsky Institute of Organic Chemistry, Russian Academy of Sciences, 47 Leninsky Prosp., 119991 Moscow, Russia.ORCID 0000-0001-7862-2895
Jemma ArakelyanDrug Discovery Lab, Department of Chemistry, City University of Hong Kong, 83 Tat Chee Avenue, Hong Kong SAR, China.ORCID 0000-0002-0012-8536
Ivan V AnanyevN.S. Kurnakov Institute of General and Inorganic Chemistry, Russian Academy of Sciences, GSP-1, Leninsky prospect, 31, 119991 Moscow, Russia.ORCID 0000-0001-6867-7534
Artem L GushchinA.V. Nikolaev Institute of Inorganic Chemistry, Siberian Branch of Russian Academy of Sciences, 3 Academician Lavrentiev Ave., 630090 Novosibirsk, Russia.ORCID 0000-0003-3214-1433
Leonid L FershtatN.D. Zelinsky Institute of Organic Chemistry, Russian Academy of Sciences, 47 Leninsky Prosp., 119991 Moscow, Russia.ORCID 0000-0002-0203-1025
Maria V BabakDrug Discovery Lab, Department of Chemistry, City University of Hong Kong, 83 Tat Chee Avenue, Hong Kong SAR, China.ORCID 0000-0002-2009-7837

Funding

Pneumoconiosis Compensation Fund Board of Hong Kong 9211315Russian Science Foundation 19-73-20074-P
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antiproliferative activityfuroxanmalignant pleural mesotheliomamechanism of actionnitrogen heterocyclesNO donorsoxadiazole

Identifiers

PMID41304830
PMCPMC12656327

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.